Feigrisolide A

Details

Top
Internal ID 56df2362-bad8-45a1-8868-ef6652bd447c
Taxonomy Organoheterocyclic compounds > Lactones
IUPAC Name (3R,4S,7S)-4-hydroxy-7-[(2S)-2-hydroxypropyl]-3-methyloxepan-2-one
SMILES (Canonical) CC1C(CCC(OC1=O)CC(C)O)O
SMILES (Isomeric) C[C@@H]1[C@H](CC[C@H](OC1=O)C[C@H](C)O)O
InChI InChI=1S/C10H18O4/c1-6(11)5-8-3-4-9(12)7(2)10(13)14-8/h6-9,11-12H,3-5H2,1-2H3/t6-,7+,8-,9-/m0/s1
InChI Key FZPDDULMNZBINH-KZVJFYERSA-N
Popularity 3 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H18O4
Molecular Weight 202.25 g/mol
Exact Mass 202.12050905 g/mol
Topological Polar Surface Area (TPSA) 66.80 Ų
XlogP 0.70
Atomic LogP (AlogP) 0.46
H-Bond Acceptor 4
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
(3R,4S,7S)-4-hydroxy-7-[(2S)-2-hydroxypropyl]-3-methyloxepan-2-one

2D Structure

Top
2D Structure of Feigrisolide A

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8593 85.93%
Caco-2 + 0.6105 61.05%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Mitochondria 0.7303 73.03%
OATP2B1 inhibitior - 0.8456 84.56%
OATP1B1 inhibitior + 0.9463 94.63%
OATP1B3 inhibitior + 0.9499 94.99%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior - 0.9706 97.06%
P-glycoprotein inhibitior - 0.9632 96.32%
P-glycoprotein substrate - 0.8394 83.94%
CYP3A4 substrate - 0.5649 56.49%
CYP2C9 substrate - 0.5888 58.88%
CYP2D6 substrate - 0.8457 84.57%
CYP3A4 inhibition - 0.7172 71.72%
CYP2C9 inhibition - 0.8853 88.53%
CYP2C19 inhibition - 0.8308 83.08%
CYP2D6 inhibition - 0.9392 93.92%
CYP1A2 inhibition - 0.8563 85.63%
CYP2C8 inhibition - 0.9920 99.20%
CYP inhibitory promiscuity - 0.9757 97.57%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.8915 89.15%
Carcinogenicity (trinary) Non-required 0.7221 72.21%
Eye corrosion - 0.9587 95.87%
Eye irritation - 0.7729 77.29%
Skin irritation - 0.5874 58.74%
Skin corrosion - 0.8272 82.72%
Ames mutagenesis - 0.7670 76.70%
Human Ether-a-go-go-Related Gene inhibition - 0.6949 69.49%
Micronuclear - 0.9400 94.00%
Hepatotoxicity + 0.5991 59.91%
skin sensitisation - 0.8481 84.81%
Respiratory toxicity - 0.5444 54.44%
Reproductive toxicity - 0.5212 52.12%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity + 0.5486 54.86%
Acute Oral Toxicity (c) III 0.6064 60.64%
Estrogen receptor binding - 0.6280 62.80%
Androgen receptor binding - 0.8353 83.53%
Thyroid receptor binding - 0.6941 69.41%
Glucocorticoid receptor binding - 0.6512 65.12%
Aromatase binding - 0.8181 81.81%
PPAR gamma - 0.9043 90.43%
Honey bee toxicity - 0.9636 96.36%
Biodegradation - 0.6000 60.00%
Crustacea aquatic toxicity - 0.7800 78.00%
Fish aquatic toxicity + 0.7910 79.10%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 97.96% 85.14%
CHEMBL2581 P07339 Cathepsin D 94.57% 98.95%
CHEMBL253 P34972 Cannabinoid CB2 receptor 92.49% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 90.07% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 89.27% 91.11%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.92% 97.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.81% 95.56%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 82.97% 95.89%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 81.50% 96.47%
CHEMBL1806 P11388 DNA topoisomerase II alpha 81.09% 89.00%

Cross-Links

Top
PubChem 11820158
NPASS NPC31965
LOTUS LTS0126168
wikiData Q105005086